2 weeks Ago
Pfizer, Inc. ( NYSE: PFE ) Q3 2024 Earnings Conference Call October 29, 2024 10:00 AM ET Company Participants Francesca DeMartino - Chief Investor Relations Officer & SVP Albert Bourla - Chairman & CEO Dave Denton - CFO Mikael Dolsten - Chief Scientific Officer and President of Research & Development Chris Boshoff - EVP & Chief Oncology Officer Alexandre de Germay - EVP & Chief International Commercial Officer Conference Call Participants Chris Shibutani - Goldman Sachs Kripa Devarakonda - Truist Umer Raffat - Evercore Trung Huynh - UBS Louise Chen - Cantor Geoff Meacham - Citi Terence Flynn - Morgan Stanley Evan Seigerman - BMO Capital Markets Courtney Breen - Bernstein Steve Scala - TD Cowen Rajesh Kumar - HSBC Akash Tewari - Jefferies Vamil Divan - Guggenheim Securities Dave Risinger - Leerink Partners Chris Schott - JPMorgan Mohit Bansal - Wells Fargo Operator Good day, everyone, and welcome to Pfizer's Third Quarter 2024 Earnings Conference Call. Today's call is being recorded.
At this time, I would like to turn the call over to Francesca DeMartino, Chief Investor Relations Officer and Senior Vice President. Please go ahead, ma'am. Francesca DeMartino Good morning, and welcome to Pfizer's earnings call.
I'm Francesca DeMartino, Chief Investor Relations Officer. On behalf of the Pfizer team, thank you for joining us. This call is being made available via audio webcast at pfizer.
com. Earlier this morning, we released our results for the third quarter of 2024 via a press release that is available on our website at pfizer.com.
I'm joined today by Dr. Albert Bourla, our Chairman and CEO; and Dave Denton, our CFO. Albert and Dave have some prepared remarks, and we will then open the call for questions.
Members of our leadership team will be available for the Q&A session, including Dr. Andrew Baum, who recently joined Pfizer as EVP and Chief Strategy and Innovation Officer..
